Table 1 Comparison of the general characteristics of patients with ESBL-positive and -negative KPLA

 Age (mean age ± SD)

60.8 ± 8.5

59.3 ± 13.3

0.95

 Male, n (%)

7 (50%)

50 (58.14%)

0.57

 Diabetes

10 (71.43%)

45 (66.2%)

0.086

 Gastrointestinal malignancy

7 (50%)

6 (6.98%)

< 0.001

 History of biliary disease

11 (78.57%)

23 (26.74%)

< 0.001

 Fever (>  38.5 °C)

13 (92.86%)

82 (95.34%)

0.693

 Chills

8 (57.14%)

66 (77.74%)

0.123

 Nausea and/or vomiting

6 (42.86%)

21 (24.42%)

0.152

 Endophthalmitis

0 (0%)

2 (2.35%)

0.566

Duration of antibiotic treatment (mean days ± SD)

16.36 ± 13.92

9.25 ± 4.96

0.59

30 days mortality, n (%)

2 (14.29%)

2 (2.33%)

0.093

ICU admission, n (%)

4 (28.57%)

2 (2.33%)

< 0.001